Melatoninergic neuroprotection of the murine periventricular white matter against neonatal excitotoxic challenge

Annals of Neurology

Volumn 51, Issue 1, 2002, Pages 82-92

  Husson, Isabelle ^a   Mespls, Bettina ^a   Bac, Pierre ^a   Vamecq, Joseph ^b   Evrard, Philippe ^b   Gressens, Pierre ^a,c  

^a INSERM   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c Service de Neurologie Pdiatrique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 PHENYL 2 PROPIONOMIDOTETRALINE; ACETYLCYSTEINE; ADENYLATE CYCLASE ACTIVATOR; BISINDOLYLMALEIMIDE; FORSKOLIN; IBOTENIC ACID; LUZINDOLE; MELATONIN; MELATONIN DERIVATIVE; MELATONIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PRAZOSIN; PROTEIN KINASE C INHIBITOR; TETRALIN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CYST; BRAIN INJURY; CONTROLLED STUDY; DRUG EFFECT; LEUKOMALACIA; MOUSE; NERVE FIBER GROWTH; NERVE SPROUTING; NEUROPROTECTION; NEUROTOXICITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; WHITE MATTER;

ANIMALS; ANIMALS, NEWBORN; ANTIOXIDANTS; CELL DEATH; CEREBRAL PALSY; CYSTINE; DENERVATION; DISEASE MODELS, ANIMAL; EXCITATORY AMINO ACID AGONISTS; FREE RADICAL SCAVENGERS; HUMANS; HYPOTHERMIA, INDUCED; IBOTENIC ACID; INFANT, NEWBORN; LEUKOMALACIA, PERIVENTRICULAR; MELATONIN; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOCORTEX; NEUROPROTECTIVE AGENTS; NEUROTOXINS; RECEPTORS, CELL SURFACE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, MELATONIN; RNA, MESSENGER; TETRAHYDRONAPHTHALENES; TRYPTAMINES;

EID: 0036135872     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10072     Document Type: Article

References (34)

1. The changing panorama of cerebral palsy in Sweden. VII. Prevalence and origin in the birth year period 1987-90
2. Antecedents of cerebral palsy. Multivariate analysis of risk
3. Melatonin: A clinical perspective
4. Melatonin add-on in manic patients with treatment resistant insomnia
5. The comparative dose-response effects of melatonin and midazolam for premedication of adult patients: A double-blinded, placebo-controlled study
6. Melatonin treatment of sleepwake cycle disorders in children and adolescents
7. Protective effect of melatonin against hippocampal DNA damage induced by intraperitoneal administration of kainate to rats
8. Glial cell survival is enhanced during melatonin-induced neuroprotection against cerebral ischemia
9. Protective effect of melatonin in a model of traumatic brain injury in mice
10. Melatonin protects primary cultures of rat cortical neurones from NMDA excitotoxicity and hypoxia/reoxygenation
11. Melatonin protects against ischemia and reperfusion-induced oxidative lipid and DNA damage in fetal rat brain
12. Melatonin, hydroxyl radical-mediated oxidative damage, and aging: A hypothesis
13. Pharmacological actions of melatonin in oxygen radical pathophysiology
14. Cell protective role of melatonin
15. Melatonin effect on behavior: Possible mediation by the central GABAergic system
16. Magnesium-deficiency-dependent audiogenic seizures (MDDASs) in adult mice: A nutritional model for discriminatory screening of anticonvulsivant drugs and original assessment of neuroprotection properties
17. Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses
18. Molecular characterization of a second melatonin receptor expressed in human retina and brain: The Mel1b melatonin receptor
19. Melatonin receptors
20. The Mel1a melatonin receptor is coupled to parallel signal transduction pathways
21. Melatonin binding sites are functionally coupled to phosphoinositide hydrolysis in syrian hamster RPMI 1846 melanoma cells
22. Multiple restricted origin of oligodendrocytes
23. Melatonin: A major regulator of the circadian rhythm of core temperature in humans
24. Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance
25. Effect of ibotenate on brain development: An excitotoxic mouse model of microgyria and posthypoxic like lesions
26. Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain
27. Regulation of neuroprotective action of vasoactive intestinal peptide in the murine developing brain by protein kinase C and mitogen-activated protein cascades: In vivo and in vitro studies
28. Central role of microglia in neonatal excitotoxic lesions of the murine periventricular white matter
29. Melatonin receptor antagonists that differenciate between the human Mel 1a and Mel 1b recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 presynaptic heteroreceptor
30. Pharmacological characterization of melatonin binding sites in Syrian hamster hypothalamus
31. Proinflammatory cytokines and IL-9 exacerbate excitotoxic lesions of the newborn murine neopallium
32. Protective effects of moderate hypothermia after neonatal hypoxia-ischemia: Shortand long-term outcome
33. Specific inhibition of apoptosis after cerebral hypoxia-ischaemia by moderate postinsult hypothermia
34. Melatonin inhibits expression of the inducible isoform of nitric oxide synthase in murine macrophages: Role of inhibition of NF kappa B activation